YU46988B - Postupak za proizvodnju preparata koji sadrže azelastin - Google Patents

Postupak za proizvodnju preparata koji sadrže azelastin

Info

Publication number
YU46988B
YU46988B YU209288A YU209288A YU46988B YU 46988 B YU46988 B YU 46988B YU 209288 A YU209288 A YU 209288A YU 209288 A YU209288 A YU 209288A YU 46988 B YU46988 B YU 46988B
Authority
YU
Yugoslavia
Prior art keywords
azelastine
solution
physiologically tolerable
tolerable salt
mixed
Prior art date
Application number
YU209288A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU209288A (en
Inventor
H. Hettche
Original Assignee
Asta Medica Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6340483&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU46988(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Medica Ag. filed Critical Asta Medica Ag.
Priority to SI8812092A priority Critical patent/SI8812092A/sl
Publication of YU209288A publication Critical patent/YU209288A/xx
Priority to HRP-2092/88A priority patent/HRP920668B1/xx
Publication of YU46988B publication Critical patent/YU46988B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
YU209288A 1987-11-13 1988-11-10 Postupak za proizvodnju preparata koji sadrže azelastin YU46988B (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI8812092A SI8812092A (sl) 1987-11-13 1988-11-10 Postopek za proizvodnjo zdravilnih preparatov, ki vsebujejo azelastin za uporabo v nosu in/ali v očesu
HRP-2092/88A HRP920668B1 (en) 1987-11-13 1992-09-30 Preparations containing azelastine for application in the nose and/or to the eye

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3738681 1987-11-13

Publications (2)

Publication Number Publication Date
YU209288A YU209288A (en) 1990-04-30
YU46988B true YU46988B (sh) 1994-09-09

Family

ID=6340483

Family Applications (1)

Application Number Title Priority Date Filing Date
YU209288A YU46988B (sh) 1987-11-13 1988-11-10 Postupak za proizvodnju preparata koji sadrže azelastin

Country Status (15)

Country Link
US (1) US5164194A (enExample)
EP (1) EP0316633B1 (enExample)
JP (3) JP2911460B2 (enExample)
AT (1) ATE84968T1 (enExample)
AU (1) AU613107B2 (enExample)
CA (1) CA1319322C (enExample)
DE (1) DE3877904D1 (enExample)
DK (1) DK174928B1 (enExample)
ES (1) ES2053678T3 (enExample)
GR (1) GR3007202T3 (enExample)
IE (1) IE61562B1 (enExample)
NL (1) NL990011I1 (enExample)
PT (1) PT88985B (enExample)
YU (1) YU46988B (enExample)
ZA (1) ZA888461B (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2051726T3 (es) * 1987-01-17 1994-07-01 Asta Medica Ag Procedimiento para preparar productos inyectables que contienen azelastin y teofilina o azelastin y beta-mimeticos.
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP4138910B2 (ja) 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
JP2005281315A (ja) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc 水性薬理組成物
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
CN1413112A (zh) * 1999-11-11 2003-04-23 武田药品工业株式会社 含有稠合哒嗪衍生物的滴鼻剂
US7833549B2 (en) * 2000-01-19 2010-11-16 Mannkind Corporation Dry powder formulations of antihistamine for nasal administration
DE10007203A1 (de) 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
DE20009841U1 (de) * 2000-05-31 2001-10-25 Phyt-Immun GmbH, 66424 Homburg Nasensalbe auf Basis von Vaselin
JP3450805B2 (ja) 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
AU2002236781A1 (en) * 2001-01-18 2002-07-30 Medpointe Healthcare Inc. Treatment for snoring
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US7977376B2 (en) * 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
US6641799B2 (en) 2002-04-03 2003-11-04 Nos Spray, Inc. Nasal spray for decongesting nasal passages
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CA2495830C (en) 2002-08-30 2012-08-21 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
JP2007501252A (ja) * 2003-08-05 2007-01-25 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調整剤を含有する製剤
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
AU2005210086A1 (en) * 2004-02-06 2005-08-18 Meda Pharma Gmbh & Co. Kg Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
PL2486942T3 (pl) * 2004-11-24 2019-05-31 Meda Pharmaceuticals Inc Kompozycje zawierające azelastynę oraz sposoby ich stosowania
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
GB2423711B (en) 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
US7378082B1 (en) * 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
BRPI0821647A2 (pt) * 2007-12-21 2015-06-16 Schering Plough Healthcare Realce da fotosestabillização de oximetazolina
US8642069B2 (en) * 2008-08-27 2014-02-04 Alexander D. Goldin Composition and method for treating colds
KR101261230B1 (ko) 2010-11-29 2013-05-07 한림제약(주) 모메타손 푸로에이트 및 아젤라스틴 염산염을 포함하는 비내 투여용 약학 조성물
EP2968323A4 (en) 2013-03-13 2016-12-14 Flatley Discovery Lab PYRIDAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
ES2937145T3 (es) * 2020-05-29 2023-03-24 CEBINA GmbH Azelastina como tratamiento antiviral
AU2021291684A1 (en) 2020-06-15 2022-12-08 Alkem Laboratories Limited Combination of alcaftadine and a corticosteroid
US20240173331A1 (en) 2021-04-01 2024-05-30 Alkem Laboratories Limited Nasal compositions comprising alcaftadine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US158564A (en) * 1875-01-12 Improvement in medicine-droppers
US2119643A (en) * 1934-11-07 1938-06-07 Mendl Viktor Pressure-operated diffuser of toilet-liquids
US2136940A (en) * 1936-07-02 1938-11-15 Aromel Corp Atomizer
US2457024A (en) * 1945-02-13 1948-12-21 Arp Claus Collapsible tube holder
US2995308A (en) * 1958-09-23 1961-08-08 American Home Prod Jet stream dispenser
CH572914A5 (enExample) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
ATE49205T1 (de) * 1984-09-14 1990-01-15 Asta Pharma Ag Substituierte benzylphthalazinon-derivate.
DE3530793A1 (de) * 1984-09-14 1986-03-27 Asta-Werke Ag Chemische Fabrik, 4800 Bielefeld Substituierte benzylphthalazinon-derivate
US4769369A (en) * 1986-11-14 1988-09-06 Pennwalt Corporation Anti-allergy 1(2H)-phthalazinones
JP6034925B2 (ja) 2015-07-07 2016-11-30 株式会社ブリヂストン 接着剤組成物、接着剤被覆繊維、ゴム物品及び空気入りタイヤ

Also Published As

Publication number Publication date
JPH11349484A (ja) 1999-12-21
ZA888461B (en) 1989-08-30
EP0316633B1 (de) 1993-01-27
DK630188A (da) 1989-05-14
DK630188D0 (da) 1988-11-11
AU2506388A (en) 1989-05-18
ES2053678T3 (es) 1994-08-01
ATE84968T1 (de) 1993-02-15
GR3007202T3 (enExample) 1993-07-30
JPH01153639A (ja) 1989-06-15
PT88985A (pt) 1988-12-01
JP2911460B2 (ja) 1999-06-23
IE883403L (en) 1989-05-13
YU209288A (en) 1990-04-30
US5164194A (en) 1992-11-17
CA1319322C (en) 1993-06-22
DK174928B1 (da) 2004-03-01
NL990011I1 (nl) 1999-07-01
AU613107B2 (en) 1991-07-25
EP0316633A1 (de) 1989-05-24
JPH10182464A (ja) 1998-07-07
IE61562B1 (en) 1994-11-16
JP2956029B2 (ja) 1999-10-04
PT88985B (pt) 1993-01-29
DE3877904D1 (de) 1993-03-11
JP3207816B2 (ja) 2001-09-10

Similar Documents

Publication Publication Date Title
Baudouin et al. Calcium release induced by interaction of angiotensin with its receptors in smooth muscle cell microsomes
RU2088617C1 (ru) Трансдермальная безводная композиция, способ ее получения и нанесения
GALTON Mechanisms underlying the acceleration of thyroid hormone-induced tadpole metamorphosis by corticosterone
US4711894A (en) Stabilized tocopherol in dry, particulate, free-flowing form
DE69105106D1 (de) Im wasser schnell suspendierbare pharmazeutische zusammensetzung.
KR880002508A (ko) 세포내 지방입자(리포솜)의 제조방법 및 조성물
YU47258B (sh) Postupak za dobijanje čvrstog preparata sa produženim oslobadjanjem aktivnog jedinjenja
BR9814262A (pt) Microcapsulas com velocidades de liberação facilmente ajustáveis
MX9207569A (es) Microcapsulas, un procedimiento para su preparacion y su empleo.
EP0069097A2 (en) Pharmaceutical mixture
RU2328134C2 (ru) Кормовая добавка для животных
SE8602931D0 (sv) A controlled-release composition
ES401063A1 (es) Un metodo de preparacion de una composicion para el tenido del cabello.
Fenske et al. Effects of fungal metabolites on testosterone secretion in vitro
RU1829935C (ru) Способ получени флунаризинсодержащей композиции
KR900005963A (ko) 철 공급용 제제, 비타민 공급용 제제, 및 발포 제제의 안정화 방법
FR2536998A1 (fr) Composition contenant des composes marques par la radioactivite, stabilises par des diethylenetriamines thiocarbonylees
Rao et al. Influence of the calcium-sensitive fluorophore, Quin 2, on platelet function
BURGER et al. Labeling of thyroid hormones and their derivatives
KR840007355A (ko) 포차충증 치료제의 제조방법
Sakanashi et al. Nitroglycerin relaxes coronary artery of the pig with no change in glutathione content or glutathione S-transferase activity
Mayura et al. The effects of ochratoxin A on postimplantation rat embryos in culture
KR840006480A (ko) 유기화합물 및 이의 제조방법
Harms et al. Hypoprothrombinemia induced by gossypol.
RU1835290C (ru) Состав дл лечени аммиачных ожогов глаз